Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 306 (5697): 876-879

Copyright © 2004 by the American Association for the Advancement of Science

Abnormal Cytokinesis in Cells Deficient in the Breast Cancer Susceptibility Protein BRCA2

Matthew J. Daniels,* Yunmei Wang,* MiYoung Lee, Ashok R. Venkitaraman{dagger}

Abstract: Germ-line mutations inactivating BRCA2 predispose to cancer. BRCA2-deficient cells exhibit alterations in chromosome number (aneuploidy), as well as structurally aberrant chromosomes. Here, we show that BRCA2 deficiency impairs the completion of cell division by cytokinesis. BRCA2 inactivation in murine embryo fibroblasts (MEFs) and HeLa cells by targeted gene disruption or RNA interference delays and prevents cell cleavage. Impeded cell separation is accompanied by abnormalities in myosin II organization during the late stages in cytokinesis. BRCA2 may have a role in regulating these events, as it localizes to the cytokinetic midbody. Our findings thus link cytokinetic abnormalities to a hereditary cancer syndrome characterized by chromosomal instability and may help to explain why BRCA2-deficient tumors are frequently aneuploid.

University of Cambridge, Cancer Research UK, Department of Oncology and the Medical Research Council (MRC) Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge CB2 2XZ, UK.

Back to Top

* These authors contributed equally to this work.

{dagger} To whom correspondence should be addressed. E-mail: arv22{at}cam.ac.uk


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2.
A. R. Venkitaraman (2014)
Science 343, 1470-1475
   Abstract »    Full Text »    PDF »
Protective role of RAD50 on chromatin bridges during abnormal cytokinesis.
B. Schroder-Heurich, B. Wieland, M. F. Lavin, D. Schindler, and T. Dork (2014)
FASEB J 28, 1331-1341
   Abstract »    Full Text »    PDF »
BRCA2 Phosphorylated by PLK1 Moves to the Midbody to Regulate Cytokinesis Mediated by Nonmuscle Myosin IIC.
M. Takaoka, H. Saito, K. Takenaka, Y. Miki, and A. Nakanishi (2014)
Cancer Res. 74, 1518-1528
   Abstract »    Full Text »    PDF »
Identification and Validation of an Anthracycline/Cyclophosphamide-Based Chemotherapy Response Assay in Breast Cancer.
J. M. Mulligan, L. A. Hill, S. Deharo, G. Irwin, D. Boyle, K. E. Keating, O. Y. Raji, F. A. McDyer, E. O'Brien, M. Bylesjo, et al. (2014)
J Natl Cancer Inst 106, djt335
   Abstract »    Full Text »    PDF »
Trypanosoma brucei BRCA2 acts in a life cycle-specific genome stability process and dictates BRC repeat number-dependent RAD51 subnuclear dynamics.
A. Trenaman, C. Hartley, M. Prorocic, D. G. Passos-Silva, M. v. d. Hoek, V. Nechyporuk-Zloy, C. R. Machado, and R. McCulloch (2013)
Nucleic Acids Res. 41, 943-960
   Abstract »    Full Text »    PDF »
The Kelch Protein KLHDC8B Guards against Mitotic Errors, Centrosomal Amplification, and Chromosomal Instability.
M. M. Krem, P. Luo, B. I. Ing, and M. S. Horwitz (2012)
J. Biol. Chem. 287, 39083-39093
   Abstract »    Full Text »    PDF »
The relative efficiency of homology-directed repair has distinct effects on proper anaphase chromosome separation.
C. Laulier, A. Cheng, and J. M. Stark (2011)
Nucleic Acids Res. 39, 5935-5944
   Abstract »    Full Text »    PDF »
Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function.
S. Sinha, G. Mondal, E. J. Hwang, D. W. Han, S. K. Dutta, S. Iyer, S. A. Karumanchi, K. I. Kim, F. J. Couch, and D. Mukhopadhyay (2011)
J. Cell Sci. 124, 2132-2142
   Abstract »    Full Text »    PDF »
BRCA2 and Nucleophosmin Coregulate Centrosome Amplification and Form a Complex with the Rho Effector Kinase ROCK2.
H.-F. Wang, K. Takenaka, A. Nakanishi, and Y. Miki (2011)
Cancer Res. 71, 68-77
   Abstract »    Full Text »    PDF »
brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesis.
H. R. Shive, R. R. West, L. J. Embree, M. Azuma, R. Sood, P. Liu, and D. D. Hickstein (2010)
PNAS 107, 19350-19355
   Abstract »    Full Text »    PDF »
Astrocytoma in a Breast Cancer Lineage: Part of the BRCA2 Phenotype?.
B. T. Wilson, S. F. Douglas, and T. Polvikoski (2010)
J. Clin. Oncol. 28, e596-e598
   Full Text »    PDF »
Expanded roles of the Fanconi anemia pathway in preserving genomic stability.
Y. Kee and A. D. D'Andrea (2010)
Genes & Dev. 24, 1680-1694
   Abstract »    Full Text »    PDF »
Evidence that the tumor-suppressor protein BRCA2 does not regulate cytokinesis in human cells.
S. Lekomtsev, J. Guizetti, A. Pozniakovsky, D. W. Gerlich, and M. Petronczki (2010)
J. Cell Sci. 123, 1395-1400
   Abstract »    Full Text »    PDF »
Extensive Crosstalk Between O-GlcNAcylation and Phosphorylation Regulates Cytokinesis.
Z. Wang, N. D. Udeshi, C. Slawson, P. D. Compton, K. Sakabe, W. D. Cheung, J. Shabanowitz, D. F. Hunt, and G. W. Hart (2010)
Science Signaling 3, ra2
   Abstract »    Full Text »    PDF »
Structural basis for recruitment of BRCA2 by PALB2.
A. W. Oliver, S. Swift, C. J. Lord, A. Ashworth, and L. H. Pearl (2009)
EMBO Rep. 10, 990-996
   Abstract »    Full Text »    PDF »
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells.
S. J. Salipante, M. E. Mealiffe, J. Wechsler, M. M. Krem, Y. Liu, S. Namkoong, G. Bhagat, T. Kirchhoff, K. Offit, H. Lynch, et al. (2009)
PNAS 106, 14920-14925
   Abstract »    Full Text »    PDF »
The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis.
S. Peddibhotla, M. H. Lam, M. Gonzalez-Rimbau, and J. M. Rosen (2009)
PNAS 106, 5159-5164
   Abstract »    Full Text »    PDF »
Distinct Roles of BARD1 Isoforms in Mitosis: Full-Length BARD1 Mediates Aurora B Degradation, Cancer-Associated BARD1{beta} Scaffolds Aurora B and BRCA2.
S. Ryser, E. Dizin, C. E. Jefford, B. Delaval, S. Gagos, A. Christodoulidou, K.-H. Krause, D. Birnbaum, and I. Irminger-Finger (2009)
Cancer Res. 69, 1125-1134
   Abstract »    Full Text »    PDF »
The consequences of tetraploidy and aneuploidy.
Z. Storchova and C. Kuffer (2008)
J. Cell Sci. 121, 3859-3866
   Abstract »    Full Text »    PDF »
Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin.
B. Evers, R. Drost, E. Schut, M. de Bruin, E. van der Burg, P. W.B. Derksen, H. Holstege, X. Liu, E. van Drunen, H. B. Beverloo, et al. (2008)
Clin. Cancer Res. 14, 3916-3925
   Abstract »    Full Text »    PDF »
Abnormal Cytokinesis after X-Irradiation in Tumor Cells that Override the G2 DNA Damage Checkpoint.
H. Huang, L. Fletcher, N. Beeharry, R. Daniel, G. Kao, T. J. Yen, and R. J. Muschel (2008)
Cancer Res. 68, 3724-3732
   Abstract »    Full Text »    PDF »
LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin.
H. Sudo and Y. Maru (2007)
FASEB J 21, 2086-2100
   Abstract »    Full Text »    PDF »
Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers.
L. Tryggvadottir, L. Vidarsdottir, T. Thorgeirsson, J. G. Jonasson, E. J. Olafsdottir, G. H. Olafsdottir, T. Rafnar, S. Thorlacius, E. Jonsson, J. E. Eyfjord, et al. (2007)
J Natl Cancer Inst 99, 929-935
   Abstract »    Full Text »    PDF »
BRCA2 is required for neurogenesis and suppression of medulloblastoma.
P.-O. Frappart, Y. Lee, J. Lamont, and P. J. McKinnon (2007)
EMBO J. 26, 2732-2742
   Abstract »    Full Text »    PDF »
Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrate.
D. M. Lowery, K. R. Clauser, M. Hjerrild, D. Lim, J. Alexander, K. Kishi, S.-E. Ong, S. Gammeltoft, S. A. Carr, and M. B. Yaffe (2007)
EMBO J. 26, 2262-2273
   Abstract »    Full Text »    PDF »
Targeting Fanconi Anemia/BRCA2 Pathway Defects in Cancer: The Significance of Preclinical Pharmacogenomic Models.
E. Gallmeier and S. E. Kern (2007)
Clin. Cancer Res. 13, 4-10
   Abstract »    Full Text »    PDF »
Enlazin, a Natural Fusion of Two Classes of Canonical Cytoskeletal Proteins, Contributes to Cytokinesis Dynamics.
E. Octtaviani, J. C. Effler, and D. N. Robinson (2006)
Mol. Biol. Cell 17, 5275-5286
   Abstract »    Full Text »    PDF »
Molecular pathogenesis of Fanconi anemia: recent progress.
T. Taniguchi and A. D. D'Andrea (2006)
Blood 107, 4223-4233
   Abstract »    Full Text »    PDF »
Mitotic defects in XRCC3 variants T241M and D213N and their relation to cancer susceptibility.
A. R. Lindh, S. Rafii, N. Schultz, A. Cox, and T. Helleday (2006)
Hum. Mol. Genet. 15, 1217-1224
   Abstract »    Full Text »    PDF »
Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.
S. Beetstra, C. Salisbury, J. Turner, M. Altree, R. McKinnon, G. Suthers, and M. Fenech (2006)
Carcinogenesis 27, 517-524
   Abstract »    Full Text »    PDF »
A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan.
X. Wang, X. Wu, Z. Liang, Y. Huang, M. Fenech, and J. Xue (2006)
Mutagenesis 21, 41-47
   Abstract »    Full Text »    PDF »
BRCA1 Regulates RAD51 Function in Response to DNA Damage and Suppresses Spontaneous Sister Chromatid Replication Slippage: Implications for Sister Chromatid Cohesion, Genome Stability, and Carcinogenesis.
I. Cousineau, C. Abaji, and A. Belmaaza (2005)
Cancer Res. 65, 11384-11391
   Abstract »    Full Text »    PDF »
Mechanism of Aurora-B Degradation and Its Dependency on Intact KEN and A-Boxes: Identification of an Aneuploidy-Promoting Property.
H. G. Nguyen, D. Chinnappan, T. Urano, and K. Ravid (2005)
Mol. Cell. Biol. 25, 4977-4992
   Abstract »    Full Text »    PDF »
Down-regulation of BRCA2 Expression by Collagen Type I Promotes Prostate Cancer Cell Proliferation.
L. Moro, A. A. Arbini, E. Marra, and M. Greco (2005)
J. Biol. Chem. 280, 22482-22491
   Abstract »    Full Text »    PDF »
BRCA2 Suppresses Cell Proliferation via Stabilizing MAGE-D1.
X.-x. Tian, D. Rai, J. Li, C. Zou, Y. Bai, D. Wazer, V. Band, and Q. Gao (2005)
Cancer Res. 65, 4747-4753
   Abstract »    Full Text »    PDF »
Brh2-Dss1 Interplay Enables Properly Controlled Recombination in Ustilago maydis.
M. Kojic, Q. Zhou, M. Lisby, and W. K. Holloman (2005)
Mol. Cell. Biol. 25, 2547-2557
   Abstract »    Full Text »    PDF »
Cancer susceptibility and the functions of the BRCA2 tumor suppressor.
A. R. Venkitaraman (2005)
AACR Meeting Abstracts 2005, 1461
   Abstract »
The Molecular Requirements for Cytokinesis.
M. Glotzer (2005)
Science 307, 1735-1739
   Abstract »    Full Text »    PDF »
Functional Evaluation and Cancer Risk Assessment of BRCA2 Unclassified Variants.
K. Wu, S. R. Hinson, A. Ohashi, D. Farrugia, P. Wendt, S. V. Tavtigian, A. Deffenbaugh, D. Goldgar, and F. J. Couch (2005)
Cancer Res. 65, 417-426
   Abstract »    Full Text »    PDF »
Exploiting the DNA Repair Defect in BRCA Mutant Cells in the Design of New Therapeutic Strategies for Cancer.
A.N.J. TUTT, C.J. LORD, N. MCCABE, H. FARMER, N. TURNER, N.M. MARTIN, S.P. JACKSON, G.C.M. SMITH, and A. ASHWORTH (2005)
Cold Spring Harb Symp Quant Biol 70, 139-148
   Abstract »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882